CinCor Pharma, Inc.

Ownership Transactions Reported by 19 Insiders

Industry
Pharmaceutical Preparations
Location
230 Third Ave., 6 Th Floor, Waltham, MA

There are no Buy or Sell transactions made by insiders since 9/13/2023

CinCor Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
General Atlantic Genpar (Bermuda), L.P. 10%+ Owner $245M Aug 11, 2022
General Atlantic, L.P. 10%+ Owner $245M Aug 11, 2022
Sofinnova Venture Partners X, L.P. 10%+ Owner $175M Aug 11, 2022
Sofinnova Partners SAS 10%+ Owner $121M Aug 15, 2022
CinRx Pharma, LLC 10%+ Owner $104M Jan 11, 2022
Mary Theresa Coelho EVP CFO & Chief BD Officer $2.88K Jan 11, 2022
5AM Partners VI, LLC 10%+ Owner Feb 24, 2023
General Atlantic (CIN), L.P. 10%+ Owner Jan 6, 2022
Mason Freeman Chief Medical Officer Jan 26, 2023
Catherine Pearce Chief Operating Officer Feb 24, 2023
Maina Bhaman Director Jan 6, 2022
Marc de Garidel Chief Executive Officer, Director Feb 24, 2023
David D. Allison Director Feb 24, 2023
Jason Pitts Director Jan 6, 2022
John F. Thero Director Feb 24, 2023
James Healy Director, 10%+ Owner Nov 28, 2022
June Lee Director Feb 24, 2023
Michael W. Kalb EVP & Chief Financial Officer Feb 24, 2023
Troy A. Ignelzi Director Feb 24, 2023

Recent Insider Transactions by Companies or Individuals for CinCor Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.